Literature DB >> 3490922

Present status of yellow fever: memorandum from a PAHO meeting.

.   

Abstract

An international seminar on the treatment and laboratory diagnosis of yellow fever, sponsored by the Pan American Health Organization (PAHO) and held in 1984, differed from previous meetings on yellow fever because of its emphasis on the care and management of patients and because the participants included specialists from several branches of medicine, such as hepatology, haematology, cardiology, infectious diseases, pathology and nephrology. The meeting reviewed the current status of yellow fever and problems associated with case-finding and notification; features of yellow fever in individual countries of Latin America; health services and facilities for medical care as they relate to diagnosis and management of cases; prevention strategies for and current status of immunization programmes; clinical and pathological aspects of yellow fever in humans; pathogenesis and pathophysiology of yellow fever in experimental animal models; clinical and specific laboratory diagnosis; treatment of the disease and of complications in the functioning of individual organ systems; prognosis and prognostic indicators; and directions for future clinical and experimental research on pathophysiology and treatment.

Entities:  

Mesh:

Year:  1986        PMID: 3490922      PMCID: PMC2490888     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  14 in total

1.  The FENa test. Use in the differential diagnosis of acute renal failure.

Authors:  C H Espinel
Journal:  JAMA       Date:  1976-08-09       Impact factor: 56.272

2.  [Proteinuria, proteinaemia, and serum transaminase activity in 23 confirmed cases of yellow fever].

Authors:  J L Oudart; M Rey
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

3.  [Labrea hepatitis (Labrea black fever) and other fulminant forms of hepatitis in Sena Madureira, Acre and Boca do Acre, Amazonas, Brazil].

Authors:  G Bensabath; L B Dias
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1983 Jul-Aug       Impact factor: 1.846

4.  Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution.

Authors:  C M Rice; E M Lenches; S R Eddy; S J Shin; R L Sheets; J H Strauss
Journal:  Science       Date:  1985-08-23       Impact factor: 47.728

5.  Labrea hepatitis--hepatitis B and delta antigen expression in liver tissue: report of three autopsy cases.

Authors:  J C de Fonseca; L C Gayotto; L C Ferreira; J R Araújo; W D Alecrim; R T Santos; J P Simonetti; V A Alves
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1985 Jul-Aug       Impact factor: 1.846

6.  Myocardial and pancreatic necrosis induced by Rocio virus, a new flavivirus.

Authors:  A K Harrison; F A Murphy; J J Gardner; S P Bauer
Journal:  Exp Mol Pathol       Date:  1980-02       Impact factor: 3.362

7.  The original haemorrhagic fever: yellow fever.

Authors:  L H Dennis; B E Reisberg; J Crosbie; D Crozier; M E Conrad
Journal:  Br J Haematol       Date:  1969-11       Impact factor: 6.998

8.  Effect of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid complex on yellow fever in rhesus monkeys (Macaca mulatta).

Authors:  E L Stephen; M L Sammons; W L Pannier; S Baron; R O Spertzel; H B Levy
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

9.  Detection of yellow fever virus in serum by enzyme immunoassay.

Authors:  T P Monath; R R Nystrom
Journal:  Am J Trop Med Hyg       Date:  1984-01       Impact factor: 2.345

10.  Immunoperoxidase detection of Yellow Fever virus after natural and experimental infections.

Authors:  S M de la Monte; A L Linhares; A P da Rosa; F P Pinheiro
Journal:  Trop Geogr Med       Date:  1983-09
View more
  1 in total

1.  Yellow fever risk assessment in the Central African Republic.

Authors:  J Erin Staples; Mawlouth Diallo; Kristen B Janusz; Casimir Manengu; Rosamund F Lewis; William Perea; Sergio Yactayo; Amadou A Sall
Journal:  Trans R Soc Trop Med Hyg       Date:  2014-06-19       Impact factor: 2.184

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.